Clinical Trials Logo
  1. Home
  2. Neonatal Respiratory Distress
  3. NCT03582930

Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

Neonatal Respiratory Distress Clinical Trial

Official title:
Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

Clinical Trial Summary

Surfactant replacement therapy can be life-saving for newborn infants born with symptomatic lung surfactant deficiency causing Respiratory Distress Syndrome (RDS). Currently, such therapy requires instillation of a liquid suspension into the trachea through an endotracheal tube. Endotracheal intubations have undesirable adverse effects on fragile premature infants. Instilling surfactant as a liquid suspension into the lung is associated with adverse events due to interruption of breathing in patients who already have respiratory insufficiency. This treatment protocol is expanded access that offers the opportunity for patients to receive aerosolized Infasurf prior to FDA acting on ONY Biotech's application for approval for commercial marketing of aerosolized Infasurf.

Clinical Trial Description

This Treatment Protocol will offer patients access to aerosolized Infasurf therapy at the time RDS is diagnosed if a patient is <12 hours of age and has not previously received liquid surfactant, or is <24 hours of age, and received liquid surfactant in the first hour after birth, was extubated and RDS is worsening. Parents must give informed consent. Up to 2 repeat doses of aerosolized Infasurf can be administered. Aerosolized Infasurf must be administered as described in the protocol. Adverse events at administration (if any) and all serious adverse events related or possibly related the aerosolized Infasurf therapy will be extracted from the medical record and reported to the sponsor, ONY Biotech. A copy of the discharge summary of patients will be collected by the sponsor using HIPAA compliant methodology for generation of a data set that will characterize adverse events and other efficacy and safety data. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03582930
Study type Expanded Access
Source ONY
Contact
Status No longer available
Phase
View Details
See also
  Status Clinical Trial Phase
Terminated NCT05030012 - Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants N/A
Active, not recruiting NCT04780412 - Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section Phase 3
Completed NCT05257499 - In-person Versus Online Debriefing in HBB N/A
Terminated NCT04096235 - A Study to Evaluate the Use of the Neotech RAM Nasal Cannula for CPAP and Bi-PAP Application in Infants 28-42 Weeks Gestation in a Neonatal Intensive Care Unit (NICU) N/A
Recruiting NCT05737095 - Study of the Feasibility of Early Lung Ultrasound in Neonatal Respiratory Distress in Premature Newborns Born Between 32 Weeks of Amenorrhea and 36 Weeks Plus 6 Days of Amenorrhea, Hospitalized in the Neonatal Pediatrics and Intensive Care Units of the Dijon University Hospital
Completed NCT06171867 - PNEUMACRIT Device for Neonatal Cardio Respiratory Monitoring N/A
Recruiting NCT02030691 - Tolerance of nHFPV Versus nCPAP in Neonatal Respiratory Distress N/A
Not yet recruiting NCT06292338 - Lung Sonar in Neonatal Respiratory Disorders
Not yet recruiting NCT06372951 - Lung Ultrasound in Neonatal Intensive Care Units
Not yet recruiting NCT05144724 - Volume Targeted Mask Ventilation Versus Pressure Ventilation in Preterm Infants N/A
Completed NCT06198478 - Tandem: Skin-to-skin Transfer From the Delivery Room to the Neonatal Unit
Recruiting NCT06356909 - Study of PREMEdication Before Laryngoscopy in Neonates in France
Recruiting NCT03239327 - Vaginal Misoprostol to Improve the Neonatal Respiratory Outcome N/A
Completed NCT04051762 - A Comparative Study Between Postextubation of Preterm Infants Into High-Flow Nasal Cannulae V.S Nasal Continuous Positive Airway Pressure
Not yet recruiting NCT03899597 - The Role of ARTificial Uterine CONtractions in Perinatal Respiratory Morbidity of Term Infants Delivered by Elective Caesarean Section N/A
Recruiting NCT02978976 - Effect of Antenatal Steroid on Pulmonary Artery Blood Flow Phase 4
Completed NCT06285669 - Effects of Kinesiotaping on Respiratory Muscles in Very Preterm Infants N/A
Recruiting NCT06207994 - PRICO: OPTI Target Range N/A
Recruiting NCT05274386 - Evaluation of the Impact of SpO2 Averaging Time on Performance of an Automatic FiO2 Control System: a Randomized Study N/A
Recruiting NCT02020993 - Urine NT-ProBNP in Neonatal Respiratory Distress N/A